title: [Detection of Abl kinase domain point mutations in chronic myeloid leukemia patients with imatinib resistance and its clinical significance].
authors.forename: Hong-li
authors.initials: HL
authors.lastname: Gu
authors.forename: Jin
authors.initials: J
authors.lastname: Wang
authors.forename: Zheng-hong
authors.initials: ZH
authors.lastname: Qin
mesh_terms: D000328:Adult; D000368:Aged; D001549:Benzamides / Q000494:pharmacology*; D019008:Drug Resistance, Neoplasm / Q000235:genetics*; D006801:Humans; D000068877:Imatinib Mesylate; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000235:genetics*; D008875:Middle Aged; D010879:Piperazines / Q000494:pharmacology*; D017354:Point Mutation; D011743:Pyrimidines / Q000494:pharmacology*
chemical_list: D001549:Benzamides; D010879:Piperazines; D011743:Pyrimidines; D000068877:Imatinib Mesylate